Posted in M&A / Deals Sidewinder secures $137M to advance ‘precision’ ADCs April 8, 2026 BioPharma Dive Backed by OrbiMed, Novartis venture arm and many other investors, the biotech is among those working on newer technology that could broaden the reach of antibody-drug conjugates. M&A / DealsOncologyRead full story